In den Warenkorb
Bestellen Sie auch über:
![]() |
+49 (0)241 95 163 153 |
![]() |
+49 (0)241 95 163 155 |
Tumor Protein P53 (TP53) (pSer392) Antikörper
| Antigen | Tumor Protein P53 (TP53) |
| Synonyme | p53, LFS1, TRP53, FLJ92943, P53, Trp53, MGC112612, brp53, drp53, fb40d06, wu:fb40d06, zgc:111919, TP53, bbl, bfy, bhy, p44, Tp53, tp53 |
| Epitope |
Alternativen pSer392 |
| Klonalität | Monoklonal (FP3-2 [FPS392]) |
| Wirt |
Alternativen Maus |
| Reaktivität |
Alternativen Human |
| Applikation |
Alternativen Western Blot (WB), Immunhistochemie (Paraffinschnitte) (IHC (p))
|
![]() |
1 Publikation vorhanden |
| Produktnummer | ABIN94450 |
| Menge | 0.1 mg (1 mg/ml) |
| Preis | 230,00 € Zzgl. Versandkosten €20,00 und MWSt |
| Lieferung nach |
|
| Verfügbarkeit | Lieferung in 3 bis 5 Werktagen |
Produktbeschreibung
| Weitere Bezeichnung | p53 (Phospho-Ser392) |
| Immunogen | KLH-conjugated phosphopeptide RHKKLMFKTEGPDS[P]D, corresponding to amino acids378-393 of human p53. |
| Format | Purified |
| Isotyp | IgG1 (Passende Sekundärantikörper) |
| Klon | FP3-2 [FPS392] |
| Beschreibung | The tumour suppressor protein p53 is a key element of intracellular anticancer protection. Itmediates cell cycle arrest or apoptosis in response to DNA damage or to starvation forpyrimidine nukleotides. It is up-regulated in response to these stress signals and stimulatedto activate transcription of specific genes, resulting in expression of p21waf1 and otherproteins involved in G1 or G2/M arrest, or proteins that trigger apoptosis, such as Bcl-2. Thestructure of p53 comprises N-terminal transactivation domain, central DNA-binding domain,oligomerisation domain, and C-terminal regulatory domain. There are variousphosphorylation sites on p53, of which the phosphorylation at Ser15 is important for p53activation and stabilization. |
| Spezifität | The antibody FP3.2 [FPS392] reacts with human p53 tumour suppressor proteinphosphorylated at CKII site (Ser 392). |
Anwendungen
| Applikationshinweise | Western Blotting - Recommended dilution: 1 µg/ml. Immunohistochemistry (paraffin sections) - Staining technique: standard ABC technique (DAB+)Pretreatment: high temperature antigen retrieval (microwave, pressure cooker) in 10 mMcitrate buffer pH 6. 0 or 1 mM EDTA-NaOH buffer pH 8. 0Recommended dilution: 10 µg/ml Incubation: 1 hour at RT, or overnight at 4 o C Positive tissue: breast carcinoma with high level of wild-type p53 |
| Konzentration | 1 mg/ml |
| Reinheit | > 95% (by SDS-PAGE) |
| Reinigung | Purified from ascites by protein-A affinity chromatography. |
| Buffer | Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4 |
| Lagerung | Store at 2-8 o C. Do not use after expiration date stamped on vial label. For long-term storage aliquot and store at -20 o C. Avoid freeze/thaw cycles. |
| Beschränkungen | Nur für Forschungszwecke einsetzbar |
Bilder
Publikationen
| Publikationen |
Blaydes, Craig, Wallace et al.: "Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways." in: Oncogene, Vol. 19, Issue 34, pp. 3829-39, 2000 (PubMed).
|
Alternativen
Alternativen zu Antigen "Tumor Protein P53 (TP53)", Typ "Antikörper" finden




Alternativen